CIK 0001665988
- Accelerated filer
- Emerging growth company
Bioventus Inc.
Sign in to watch- Ticker
- BVS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 810980861
- Phone
- +1 919-474-6700
- Business address
- 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
- 4 Planned sale SVP & CFO sold 4,000 shares at $4.75 ($19,000)
- 4 Planned sale SVP & General Counsel sold 3,054 shares at $4.75 ($14,507)
- 4 Planned sale SVP & Chief Compliance Officer sold 1,325 shares at $4.75 ($6,294)
- 4 Exercise or conversion SVP & CFO acquired 13,000 shares (option exercise)
- 4 Exercise or conversion SVP & General Counsel acquired 9,925 shares (option exercise)
- 4 Exercise or conversion SVP & Chief Compliance Officer acquired 4,300 shares (option exercise)
- 4 Open-market sale SVP & CFO sold 5,541 shares at $5.39 ($29,853)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale SVP & General Counsel sold 3,125 shares at $5.46 ($17,063)
- 4 Open-market sale SVP & Chief Compliance Officer sold 1,217 shares at $5.46 ($6,645)
- 4 Exercise or conversion SVP & General Counsel acquired 8,886 shares (option exercise)
- 4 Exercise or conversion SVP & Chief Compliance Officer acquired 3,456 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4/A Other disposition Director disposed of 2,604,264 shares (other)
- 3/A Insider 3/A
- 4 Open-market buy Interim CEO bought 39,885 shares at $4.14 ($165,076)
- 4 Other acquisition Director acquired 41,369 shares (other)
Page 6 of 13 · 251 filings